Aims and objectives
NPC was initially reported in 1901 and clinically characterized in 1922[1]
NPC is a rare human malignancy with an annual rate of 0.1–1.1/100,000 people in Europe and most parts of North America.
[2]
In contrast,
highest incidence rates are noted in Southeast Asia,
Southern Asia,
Alaska and Mediterranean Basin[3]
The distinct difference in the incidence among geographic and population area implies that both environmental factors and genetic susceptibility play roles in the development of NPC [4]
NPC is strongly associated with Epstein-Barr virus infection irrespectively...
Methods and materials
A cohort of 60 Greek patients with locally advanced NPC,
were retrieved from the Hellenic Cooperative Oncology Group (HeCOG) Tumor Repository and analyzed retrospectively in the Laboratory of Molecular Oncology (MOL,
by the Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki,
Thessaloniki,
Greece).
The study population consisted of 47 (78.3%) men and 13 (21,7%) women with median age of 50,2 y ,
with locally advanced NPC and no distant metastasis. Histology,
(biopsy proven from the primary site or from cervical lymph nodes in few cases),...
Results
The median follow-up period was 133.34 months (119.8-147.18) months.
Most patients (81.7%) had stage II-III NPC (Fig5) ,
43.3% had lateral extension b with no significant difference between overall survival and the degree of extention to the parapharyngeal space (Fig 6) and 7 presented with intracranial involvement.
27 patients had A/C VEGFA-2578,
while 45% had C/T VEGF -1498 and 66.1% had A/G FAS -670.
(Table 2)
CC VEGF -1498 and A/C VEGF -2578 was more frequent in smokers (p=0.043 and p=0.038,
respectively) and GG VEGF...
Conclusion
The applications of medical imaging in cancer diagnostics and the developments in imaging technologies and computational approaches have guided the emergence of “radiomics”.The concept of radiomics and texture analysis have been applied in a number of studies,
for example on tumor differentiation and tumor prognosis[13]
By establishing the associations between genomic phenotype and imaging texture features we try to accomplise the transition from population based to a more personalized approach to guide therapy.
Personal information
1.
E.T.
Psoma,
MD
Department of Diagnostic Radiology,
Ahepa University Hospital,
Thessaloniki Greece
Phone: + 2313303489
e-mail :
[email protected]
References
Wei WI,
Sham JS: Nasopharyngeal carcinoma.
Lancet 2005,
365(9476):2041–2054
Torre LA,
Bray F,
Siegel RL,
et al.
Global cancer statistics,
2012.
CA Cancer J Clin 2015,
65:87-108.
Chou J,
Lin YC,
Kim J,
et al Nasopharyngeal carcinoma – review of the molecular mechanisms of tumorigenesis .Head Neck 2008, 30(7):946–963.
Lo KW,
To KF,
Huang DP.
Focus on nasopharyngeal carcinoma.
Cancer cell 2004,
5(5):423–428.
Busson P,
Keryer C,
Ooka T,
Corbex M: EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies.
Trends Microbiol 2004,
12(8):356–360.
Kontos CK,...